PRODUCT LITERATURE

Breast cancer trial with erythropoietin terminated unexpectedly

---

Many clinical studies have shown an association between tumour oxygenation, higher haemoglobin concentrations, and improved survival in patients with cancer.1–6 And, in a recent prospective, randomised study, a subpopulation of anaemic patients with metastatic breast cancer were shown to survive longer if given erythropoietin to correct their haemoglobin concentration during chemotherapy than if treated with placebo

---

Availability

Detail Information

Series Title

-

Call Number

-

Publisher

: .,

Collation

-

Language

English

ISBN/ISSN

-

Classification

NONE

Content Type

-

Media Type

-

Carrier Type

-

Edition

-

Subject(s)

NESP

Specific Detail Info

THE LANCET Oncology Vol 4 August 2003

Statement of Responsibility

-

Other version/related

File Attachment

Comments

---

You must be logged in to post a comment